The Study of PIK3CA Hotspot Mutations and Co-Occurring with EGFR, KRAS, and TP53 Mutations in Non-Small Cell Lung Cancer
PIK3CA co-occurring mutations in other genes may represent distinct subsets of NSCLC. Further elucidation of the roles of PIK3CA hotspot mutations combined with other driver mutations, including EGFR and KRAS, is needed to guide effective treatment in patients with advanced NSCLC.
Authors
- Juanfen Mo (ORCID: https://orcid.org/0000-0002-5858-1659)
- Yuhong Shen (ORCID: https://orcid.org/0009-0005-5490-0332)
- Y. Zhang (ORCID: https://orcid.org/0000-0002-6485-4844)
- Jiayuan Wu (ORCID: https://orcid.org/0000-0002-5064-1944)
- Jun Zhang (ORCID: https://orcid.org/0000-0002-9709-8854)
- Yi Bao (ORCID: https://orcid.org/0000-0001-7144-5849)
- Chenxi Cao
Institutions
- Zhejiang Chinese Medical University (CN)
- Jiaxing University (CN)
- First Hospital of Jiaxing (CN)
Publication Details
- Journal
- OncoTargets and Therapy
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/ott.s468352
- Citations
- 3
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.26